Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Taurolidine Lock Solution”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Post-approval studies (Phase 4)UnknownNCT01948245
What this trial is testing

Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml.

Who this might be right for
Catheter-related Bloodstream Infection (CRBSI) Nos
Palle Bekker Jeppesen 42
Testing effectiveness (Phase 2)Study completedNCT07074821
What this trial is testing

Antimicrobial Locks for Hemodialysis Catheter Infections

Who this might be right for
Catheter Related Blood Stream InfectionHemodialysisVascular Access
Oman Ministry of Health 100
Large-scale testing (Phase 3)Study completedNCT00735813
What this trial is testing

Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia

Who this might be right for
BacteremiaNeoplasms
Aarhus University Hospital 129
Not applicableNot Yet RecruitingNCT07259421
What this trial is testing

Survey of Practices Regarding the Use of Taurolidine Lock Solutions in Patients With Insertion of a Peripherally Inserted Central Catheter (PICC) in a Vascular Access Unit

Who this might be right for
Taurolidine Lock Solution
University Hospital, Grenoble 45
Not applicableStudy completedNCT02279121
What this trial is testing

ATAPAC Study (TauroLock Activity in Adult Cancer Patients)

Who this might be right for
Catheter-Related Infections
Centre Hospitalier Régional Metz-Thionville 162
Post-approval studies (Phase 4)Study completedNCT02789501
What this trial is testing

Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction

Who this might be right for
Catheter InfectionsEnd-stage Renal Disease
Medical University of Vienna 106
Not applicableStudy completedNCT07366372
What this trial is testing

Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients

Who this might be right for
TaurolidineLock SolutionPrevention+2 more
Tanta University 120
Not applicableUnknownNCT05740150
What this trial is testing

Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients.

Who this might be right for
Central Line-associated Bloodstream Infection (CLABSI)
Princess Maxima Center for Pediatric Oncology 462